Gopal Kundu
Gopal Chandra Kundu is an Indian cell and cancer biologist who worked as a scientist at the Indian National Centre for Cell Science. He is known for his contributions towards the understanding the mechanism of cancer progression in breast, melanoma and other cancers and development of novel therapeutic targets and target-based therapy in cancers.
An elected fellow of the Indian Academy of Sciences and the National Academy of Sciences, India, he received the National Bioscience Award for Career Development of the Department of Biotechnology in 2003. He was awarded the Shanti Swarup Bhatnagar Prize for Science and Technology, the highest Indian science awards, in 2004.
Education and career
Kundu studied chemistry and biology at the Scottish Church College in Calcutta, India. He obtained a B.Sc. with major in chemistry from the University of Calcutta in 1980. He completed M.Sc. in chemistry at the University of Calcutta in 1982. He entered the Bose Institute, Kolkata, for a doctoral course and earned his Ph.D. in 1989 in protein biochemistry In 1989, he went to Cleveland Clinic Foundation, USA, as a post-doctoral fellow. For the next eight years, he worked as a research associate at the University of Colorado, and then as a senior research associate at the University of Wyoming and the National Institutes of Health, Bethesda. He became specialised in cardiovascular biology, inflammation and immunomodulation during that period. In 1998, he joined the National Centre for Cell Science, Pune, as Scientist-D. At NCCS, he published his most important research papers covering tumor biology, regulation of gene expression, cell signaling, angiogenesis, cancer therapeutics, biomarker studies for cancer detection, and nanomedicine.In 2019, Kundu retired from the government service at superannuation age. He was immediately appointed as director of research and development at the Kalinga Institute of Industrial Technology, a private university in Bhubaneswar, Odissa. He also holds professor positions in biotechnology at KIIT and in medicine and molecular research at Kalinga Institute of Medical Science.
He serves as Editorial Board Member of Current Molecular Medicine, Current Chemical Biology, Frontiers in Medicine, International Journal of Oncology, Molecular Medicine Reports, The Open Cancer Journal and American Journal of Cancer Research. He is an associate editor of Molecular Cancer and ''Journal of Cancer Metastasis and Treatment.''